Mylan Laboratories Limited Amlodipine Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Amlodipine Export Records India — #3 Exporter, 387 Shipments, $19.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Amlodipine

India Pharmaceutical Trade Intelligence

$11.5B599 Suppliers159 CountriesHS 30049072

ExportsIndia → GERMANY94.1%India → UNITED STATES3.6%

ImportsBULGARIA → India$4.8M ISRAEL → India$1.8M

#1 Supplier: CIPLA LIMITED #1 Buyer: B LOGISTIK

Mylan Laboratories Limited — Amlodipine Exporter #3 | $19.4M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Amlodipine Exporter Profile

Indian Pharmaceutical Exporter · #3 for Amlodipine · $19.4M export value · DGFT Verified

Mylan Laboratories Limited is the #3 Indian exporter of Amlodipine with $19.4M in export value and 387 verified shipments. Mylan Laboratories Limited holds a 0.2% market share in Amlodipine exports across 11 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Amlodipine Export Profile: Buyers & Destinations

Mylan Laboratories Limited Amlodipine export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Amlodipine?

Country	Value	Shipments	Share
UNITED STATES	$5.6M	215	53.5%
FRANCE	$2.4M	76	23.0%
HUNGARY	$1.1M	40	10.9%
NETHERLANDS	$822.2K	57

Who Are the Top Buyers of Amlodipine from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$2.6M	93
MYLAN PHARMACEUTICALS INC	UNITED STATES	$2.0M	96
M/S. MYLAN PHARMACEUTICALS INC,	UNITED STATES	$812.6K	21
MYLAN HUNGARY KFT,	HUNGARY	$610.0K	19
M/S. CSP MYLAN SAS AT CSP LABO 274	FRANCE	$538.1K	12
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$436.3K	13
MYLAN HUNGARY KFT	HUNGARY	$378.2K	13
CSP VIATRIS SANTE AT CSP LAB	FRANCE	$321.6K	8
CSP VIATRIS SANT? AT CSP- LAB,	FRANCE	$303.0K	20
CSP VIATRIS SANTE AT CSP- LAB	FRANCE	$241.8K	8

Mylan Laboratories Limited supplies Amlodipine to 56 buyers globally. The largest buyer is MYLAN PHARMACEUTICALS INC, (UNITED STATES), followed by MYLAN PHARMACEUTICALS INC (UNITED STATES) and M/S. MYLAN PHARMACEUTICALS INC, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Amlodipine Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
AMLODIPINE AND VALSARTAN TABLETS USP 10M	$565.6K	13
AMLODIPINE AND VALSARTAN TABLETS USP 10	$533.8K	11
AMLODIPINE AND VALSARTAN TABLETS USP 5MG	$442.4K	9
TELMISARTAN AND AMLODIPINE TABLETS USP 8	$343.8K	17
AMLODIPINE AND VALSARTAN TABLETS USP 5 M	$340.0K	7
AMLODIPINE AND ATORVASTATIN TABLETS USP	$334.1K	17
AMLODIPINE / VALSARTAN MYLAN 5 MG / 80 M	$313.9K	10
AMLODIPINE/VALSARTAN MYLAN 10 MG/160 MG	$252.7K	6
AMLODIPINE BESILATE TABLETS 5 MG PACKS	$190.7K	5
HARMLESS MEDICINES, AMLODIPINE BESILATE	$187.0K	7

Mylan Laboratories Limited exports 228 distinct Amlodipine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMLODIPINE AND VALSARTAN TABLETS USP 10M with 13 shipments worth $565.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Mylan Laboratories Limited Compare to Nearest Amlodipine Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	UNICHEM LABORATORIES LIMITED	$34.5M	689	9	$50.0K
5	IPCA LABORATORIES LIMITED	$21.9M	438	14	$50.0K
3	MYLAN LABORATORIES LIMITED ★	$19.4M	387	11	$50.0K
6	MACLEODS PHARMACEUTICALS LTD	$17.5M	350	36	$50.0K
7	LUPIN LIMITED	$17.4M	360	2	$48.2K

Mylan Laboratories Limited ranks #3 among 599 Indian Amlodipine exporters. Average shipment value of $50.0K compared to the market average of $519.5K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Amlodipine Exports?

Port	Shipments	% Share
SAHAR AIR	2,082	13.9%
NHAVA SHEVA SEA (INNSA1)	1,850	12.3%
JNPT/ NHAVA SHEVA SEA	1,599	10.7%
SAHAR AIR CARGO ACC (INBOM4)	1,229	8.2%
DELHI AIR	802	5.3%
DELHI AIR CARGO ACC (INDEL4)	748	5.0%
JNPT	710	4.7%
Bombay Air	417	2.8%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Amlodipine Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Amlodipine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 432 individual customs records matching Mylan Laboratories Limited exporting Amlodipine, covering 228 formulations to 12 countries via 56 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 159+ countries, 1,862+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Amlodipine

Amlodipine

Mylan Laboratories Limited — Amlodipine Exporter Profile

Mylan Laboratories Limited — Amlodipine Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Amlodipine?

Who Are the Top Buyers of Amlodipine from Mylan Laboratories Limited?

What Is India's Total Amlodipine Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Amlodipine Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Amlodipine Exporters?

What Amlodipine Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Amlodipine to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Amlodipine Exporters?

Which Indian Ports Ship Amlodipine Exports?

What Other Cardiovascular Products Does Mylan Laboratories Limited Export?

Amlodipine — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Amlodipine Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Amlodipine Export Data from Mylan Laboratories Limited

Amlodipine Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source